Breaking News Instant updates and real-time market news.

VLKAY

Volkswagen

$33.34

0.41 (1.25%)

, BMWYY

BMW

$33.30

0.22 (0.67%)

08:09
09/13/17
09/13
08:09
09/13/17
08:09

European automakers don't see EVs as solution to diesel sales drop, WSJ says

Amid declining sales of diesel-powered cars in Europe, European automakers have said demand for electric vehicles has remained too small to offset the shortfall and they wont replace diesel cars anytime soon, instead focusing on developing more gasoline-powered cars and cleaner diesel engines, the Wall Street Journal reports, citing a poll. Volkswagen (VLKAY) is planning to offer 80 electric by 2025, BMW (BMWYY) has committed to offering 25 new electric cars and hybrids by 2025, and Daimler (DDAIF) expects to offer electric versions of all its models by 2022, but said it expects half the margins on the cars compared with those they will replace. Reference Link

VLKAY

Volkswagen

$33.34

0.41 (1.25%)

BMWYY

BMW

$33.30

0.22 (0.67%)

DDAIF

Daimler AG

$78.09

0.62 (0.80%)

VLKAY Volkswagen
$33.34

0.41 (1.25%)

02/13/17
RAJA
02/13/17
NO CHANGE
RAJA
Outperform
Mobileye deal with VW has longer-term value, says Raymond James
Raymond James analyst Tavis McCourt noted that Volkswagen's (VLKAY) partnership with Mobileye (MBLY) to use REM technology in its autonomous vehicles was announced back in early 2016, but only finalized today. While the pact has "no meaningful influence" near-term, it does have longer-term financial and strategic value for Mobileye, said McCourt, who keeps an Outperform rating on the shares.
02/13/17
JEFF
02/13/17
NO CHANGE
Target $52
JEFF
Buy
Jefferies says Mobileye agreement not unexpected, but important
Mobileye's (MBLY) agreement with Volkswagen (VLKAY) is not expected given the previously disclosed memorandum of understanding, but it is important nonetheless, Jefferies analyst David Kelley tells investors in a research note. The deal substantiates Mobileye's "strong" early positioning" in the integral segment of the "rapidly developing" autonomous vehicle sector, the analyst contends. He keeps a Buy rating on the shares with a $52 price target.
04/18/17
JEFF
04/18/17
UPGRADE
JEFF
Buy
Volkswagen upgraded to Buy from Underperform at Jefferies
Jefferies analyst Philippe Jean Houchois double upgraded Volkswagen to Buy from Underperform and raised his price target for the shares to EUR 160 from EUR 110.
08/07/17
JEFF
08/07/17
DOWNGRADE
JEFF
Hold
Volkswagen downgraded to Hold from Buy at Jefferies
Jefferies analyst Philippe Houchois downgraded Volkswagen to Hold and lowered his price target for the shares to EUR 145 from EUR 160.
BMWYY BMW
$33.30

0.22 (0.67%)

03/13/17
BERN
03/13/17
INITIATION
BERN
Market Perform
BMW initiated with a Market Perform at Bernstein
Price target EUR 85.
DDAIF Daimler AG
$78.09

0.62 (0.80%)

04/21/17
BERN
04/21/17
NO CHANGE
BERN
Daimler AG named top pick among European auto makers at Bernstein
After Daimler preannounced higher than expected profit, Bernstein analyst Max Warburton says that most of the end markets of European auto makers look set to grow going forward. The analyst thinks that the heavy truck market could resume growing, and he believes that Daimler could benefit from this trend. The analyst raised his estimates on Daimler and identifies it as his top pick among European auto makers. He keeps an Outperform rating on the shares.
05/24/17
05/24/17
NO CHANGE

Perform
Opco sees limited number of competitors for Tesla's Model 3
Oppenheimer analyst Colin Rusch believes Tesla's (TSLA) Model 3 rollout is critical to its position in Advanced Driver Assist Systems. Tesla's ability to "accelerate learning cycles related to characterizing driving behavior" is facilitated by the high volume rollout of Model 3," Rusch tells investors in a research note. His channel checks indicate just fifteen models with semi-autonomous driving technology are currently available for model years 2016/2017. These cars are offered by BMW, Mercedes-Benz, Volvo, and Tesla. The analyst notes that a RAND Corporation study estimates over 11B test miles would be necessary in order to show statistically significant evidence of the autonomous vehicle's superiority over human drivers. With Model 3 enabling high mileage data collection, Tesla can accumulate the necessary mileage within just 27 months, or by mid-2021, Rusch writes. The analyst sees the potential for Tesla's ADAS value to be "significantly higher" than Mobileye's (MBLY) acquisition price if it can control the machine learning aspect of the product development. Rusch has a Perform rating on Tesla shares. The stock closed yesterday down $6.49 to $303.86.
09/06/17
GSCO
09/06/17
UPGRADE
GSCO
Buy
Daimler AG upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Stefan Burgstaller upgraded Daimler AG to Buy and raised his price target for the shares to EUR 81 from EUR 80. The analyst believes a "roadmap for structural value creation" is emerging.
09/08/17
EVER
09/08/17
UPGRADE
EVER
Outperform
Daimler AG upgraded to Outperform from In Line at Evercore ISI

TODAY'S FREE FLY STORIES

LEVB

Level Brands

$5.10

-0.0385 (-0.75%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
Level Brands, Kathy Ireland announce extension of Isodiol license agreement »

Kathy Ireland, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABAX

Abaxis

$61.16

0.35 (0.58%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
Abaxis granted USDA Approval for new VetScan FLEX4 Rapid Test »

Abaxis' new VetScan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

QURE

uniQure

$17.99

-0.01 (-0.06%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
uniQure receives OMPD in EU for AMT-130 »

uniQure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTX

BioTime

$2.64

-0.02 (-0.75%)

07:02
01/22/18
01/22
07:02
01/22/18
07:02
Hot Stocks
BioTime sees submitting Renevia for CE mark during Q1 »

BioTime expects to submit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCN

Neovasc

$0.55

0.0313 (6.02%)

07:02
01/22/18
01/22
07:02
01/22/18
07:02
Hot Stocks
Neovasc CEO Alexei Marko to depart, Fred Colen to succeed »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$57.75

-2.25 (-3.75%)

, VIA

Viacom

$39.20

-0.5 (-1.26%)

07:01
01/22/18
01/22
07:01
01/22/18
07:01
Downgrade
CBS, Viacom, Viacom rating change  »

CBS downgraded on higher…

CBS

CBS

$57.75

-2.25 (-3.75%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

AER

AerCap

$54.11

0.38 (0.71%)

07:01
01/22/18
01/22
07:01
01/22/18
07:01
Hot Stocks
AerCap leased, purchased and sold 402 aircraft in 2017 »

AerCap Holdings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

07:01
01/22/18
01/22
07:01
01/22/18
07:01
Hot Stocks
Bristol-Myers Yervoy expanded indication approved by EC »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

LRCX

Lam Research

$207.53

2.08 (1.01%)

, TSM

TSMC

$44.67

0.1 (0.22%)

07:00
01/22/18
01/22
07:00
01/22/18
07:00
Recommendations
Lam Research, TSMC, Ichor Holdings analyst commentary  »

Lam Research price target…

LRCX

Lam Research

$207.53

2.08 (1.01%)

TSM

TSMC

$44.67

0.1 (0.22%)

ICHR

Ichor Holdings

$32.39

-0.36 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 07

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

07:00
01/22/18
01/22
07:00
01/22/18
07:00
Recommendations
Apple analyst commentary  »

Wells Fargo maintains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

MB

Mindbody

$34.35

1.35 (4.09%)

06:59
01/22/18
01/22
06:59
01/22/18
06:59
Recommendations
Mindbody analyst commentary  »

Mindbody price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

06:58
01/22/18
01/22
06:58
01/22/18
06:58
Periodicals
Wal-Mart shops Brazil unit stake to Advent, other funds, Reuters reports »

Wal-Mart Stores is in…

WMT

Walmart

$104.59

0.29 (0.28%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 20

    Feb

HAL

Halliburton

$53.01

0.65 (1.24%)

06:54
01/22/18
01/22
06:54
01/22/18
06:54
Hot Stocks
Halliburton continues to experience delays in collecting payments in Venezuela »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

JNPR

Juniper

$27.85

0.19 (0.69%)

, AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

06:54
01/22/18
01/22
06:54
01/22/18
06:54
Upgrade
Juniper, Amazon.com rating change  »

Oppenheimer calls Amazon…

JNPR

Juniper

$27.85

0.19 (0.69%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 01

    Feb

  • 18

    Mar

HPQ

HP Inc.

$23.70

0.41 (1.76%)

06:54
01/22/18
01/22
06:54
01/22/18
06:54
Recommendations
HP Inc. analyst commentary  »

HP does not see sharp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

GEF

Greif

$60.82

1.13 (1.89%)

06:53
01/22/18
01/22
06:53
01/22/18
06:53
Conference/Events
Greif management to meet with Sidoti »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 29

    Mar

VR

Validus

$46.72

0.81 (1.76%)

, AIG

AIG

$61.55

0.02 (0.03%)

06:53
01/22/18
01/22
06:53
01/22/18
06:53
Hot Stocks
AIG to acquire Validus for $5.56B, or $68 per share, in cash »

American International…

VR

Validus

$46.72

0.81 (1.76%)

AIG

AIG

$61.55

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 09

    Feb

  • 20

    Feb

  • 21

    Feb

HAL

Halliburton

$53.01

0.65 (1.24%)

06:52
01/22/18
01/22
06:52
01/22/18
06:52
Hot Stocks
Halliburton CEO: On path to to normalized margins in North America in 2018 »

"Outstanding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

VR

Validus

$46.72

0.81 (1.76%)

, AIG

AIG

$61.55

0.02 (0.03%)

06:52
01/22/18
01/22
06:52
01/22/18
06:52
Hot Stocks
Breaking Hot Stocks news story on Validus, AIG »

AIG to acquire Validus…

VR

Validus

$46.72

0.81 (1.76%)

AIG

AIG

$61.55

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 09

    Feb

  • 20

    Feb

  • 21

    Feb

CELG

Celgene

$102.65

0.93 (0.91%)

, JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

06:51
01/22/18
01/22
06:51
01/22/18
06:51
Conference/Events
Celgene to host conference call »

Conference call to…

CELG

Celgene

$102.65

0.93 (0.91%)

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

HAL

Halliburton

$53.01

0.65 (1.24%)

06:50
01/22/18
01/22
06:50
01/22/18
06:50
Earnings
Halliburton reports Q4 adjusted cont ops EPS 53c, consensus 46c »

Reports Q4 revenue $5.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

BOH

Bank of Hawaii

$86.73

0.47 (0.54%)

06:49
01/22/18
01/22
06:49
01/22/18
06:49
Earnings
Bank of Hawaii reports Q4 EPS $1.01, consensus $1.07 »

Reports Q4 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

VR

Validus

$46.72

0.81 (1.76%)

06:49
01/22/18
01/22
06:49
01/22/18
06:49
Hot Stocks
Breaking Hot Stocks news story on Validus »

Validus trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

AIG

AIG

$61.55

0.02 (0.03%)

06:49
01/22/18
01/22
06:49
01/22/18
06:49
Hot Stocks
Breaking Hot Stocks news story on AIG »

AIG trading halted, news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

  • 20

    Feb

  • 21

    Feb

CBU

Community Bank System

$55.39

0.84 (1.54%)

06:48
01/22/18
01/22
06:48
01/22/18
06:48
Hot Stocks
Community Bank System raises quarterly dividend to 34c from 32c per share »

During the fourth quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.